Skip to main content

Want a detailed portfolio tracker?

Immucell (ICCC) P/E (2010 - 2026)

Immucell (ICCC) P/E from Jun 30, 2010 to Jul 21, 2026. The TTM Immucell (ICCC) P/E is -184.06. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Immucell (ICCC)

YearP/EChange
2026-184.06+240.70%
2025-54.02+187.99%
2024-18.76+152.13%
2023-7.44-89.30%
2022-69.53-41.04%
2021-117.92+369.93%
2020-25.09+58.78%
2019-15.80-5.77%
2018-16.77-121.40%
201778.37+211.98%
201625.12+2.01%
201524.63-138.47%
2014-64.01-204.29%
201361.37-110.93%
2012-561.26+2375.48%
2011-22.67-49.91%
2010-45.27N/A

Comparison Immucell (ICCC) P/E with competitors

Immucell (ICCC) P/E is -184.06.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.00%
ENLVEnlivex Ltd0.07-100.04%
FGENFibroGen Inc0.24-100.13%
CHRSCoherus Biosciences Inc0.85-100.46%
FBIOFortress Biotech Inc0.95-100.52%
ORMPOramed Pharmaceuticals Inc1.50-100.82%
AGENAgenus Inc3.01-101.64%
INVAInnoviva Inc3.15-101.71%
VXRTVaxart Inc3.55-101.93%
CRMDCorMedix Inc3.63-101.97%
CVACCureVac N.V.4.45-102.42%
GLPGGalapagos NV4.86-102.64%
SRPTSarepta Therapeutics Inc4.88-102.65%
ABEOAbeona Therapeutics Inc5.39-102.93%
ABUSArbutus Biopharma Corp5.60-103.04%
ZVRAZevra Therapeutics Inc5.89-103.20%
SPROSpero Therapeutics Inc6.23-103.38%
CGENCompugen Ltd6.31-103.43%
RIGLRigel Pharmaceuticals6.87-103.73%
SLXNSilexion Therapeutics Corp7.30-103.96%
OMEROmeros Corporation9.26-105.03%
AUPHAurinia Pharmaceuticals Inc9.58-105.21%
PLXProtalix BioTherapeutics Inc10.89-105.92%
ACADAcadia Pharmaceuticals Inc11.73-106.37%
TBPHTheravance Biopharma Inc12.26-106.66%
ADMAAdma Biologics Inc12.42-106.75%
HRMYHarmony Biosciences Holdings Inc13.82-107.51%
SABSSAB Biotherapeutics Inc14.14-107.68%
NAGENiagen Bioscience Inc14.82-108.05%
INCYIncyte Corp15.82-108.60%
REGNRegeneron Pharmaceuticals Inc15.86-108.61%
PBYIPuma Biotechnology Inc17.32-109.41%
CPRXCatalyst Pharmaceuticals Inc17.44-109.47%
EXELExelixis Inc17.54-109.53%
TGTXTG Therapeutics Inc18.97-110.30%
MDXGMimedx Group Inc20.55-111.17%
XOMAXOMA Royalty Corp22.87-112.43%
ARGXArgen X SE24.30-113.20%
CTMXCytomX Therapeutics Inc24.82-113.49%
XOMAOXOMA Royalty Corp25.34-113.77%
HALOHalozyme Therapeutics Inc25.62-113.92%
XOMAPXOMA Royalty Corp25.67-113.95%
VRTXVertex Pharmaceuticals Inc27.99-115.21%
RPRXRoyalty Pharma plc - Class A28.69-115.59%
SLNOSoleno Therapeutics Inc29.02-115.76%
ASNDAscendis Pharma A/S30.09-116.35%
LGNDLigand Pharmaceuticals Inc - Class B37.91-120.60%
APLSApellis Pharmaceuticals Inc39.02-121.20%
BMRNBiomarin Pharmaceutical Inc42.21-122.93%
KRYSKrystal Biotech Inc45.34-124.64%
ONCBeiGene Ltd69.54-137.78%
PHARPharming Group N.V.75.03-140.76%
TECHBio-Techne Corp101.96-155.39%
VCELVericel Corp109.92-159.72%
ALNYAlnylam Pharmaceuticals Inc117.96-164.09%
GMABGenmab140.29-176.22%
TLXTelix Pharmaceuticals Ltd162.15-188.10%
CORTCorcept Therapeutics Inc212.86-215.65%